Drug
salvianolate injection
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_4
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Other(4)
Detailed Status
unknown4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 43 (75.0%)
N/A1 (25.0%)
Trials by Status
unknown4100%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin
NCT03306550
unknownphase_4
Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
NCT03045562
unknownphase_4
Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
NCT03037047
unknownphase_4
Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
NCT02694848
Clinical Trials (4)
Showing 4 of 4 trials
NCT03306550Not Applicable
Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin
NCT03045562Phase 4
Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
NCT03037047Phase 4
Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
NCT02694848Phase 4
Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4